The removal comes after the FDA convened a panel of experts to weigh in, a change from past process.
FDA ASHP split estradiol patch shortage as menopause treatment demand rises, with FDA working to increase supply despite ASHP shortage listings.
AUSTIN (Nexstar) — The Texas House of Representatives subcommittee on Maternal Health, Menopause and Access to Evidence-Based Medicine had their second interim hearing Monday where they focused on ...